Marya Liimatta
Frontier Medicines (United States)
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Cannabis and Cannabinoid Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain(2009)440 cited
- → Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids.(1994)303 cited
- → Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain(2011)229 cited
- → Novel Mechanistic Class of Fatty Acid Amide Hydrolase Inhibitors with Remarkable Selectivity(2007)214 cited
- → Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor(2010)196 cited
- → Structure-guided inhibitor design for human FAAH by interspecies active site conversion(2008)151 cited
- → Dietary polyunsaturated fatty acid regulation of gene transcription(1996)135 cited
- → Lead identification of novel and selective TYK2 inhibitors(2013)122 cited
- → Dietary polyunsaturated fatty acids interfere with the insulin/glucose activation of L-type pyruvate kinase gene transcription.(1994)99 cited
- → Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors(2012)92 cited